Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Position Trading Forum -- Ignore unavailable to you. Want to Upgrade?

To: Tim Luke who wrote (6337)	11/11/1998 9:17:00 AM
From: Toni Wheeler	Respond to of 7247

Mornin' Tim, This should be a boost to this languishing stock this morn: <<University of Pittsburgh's "Healthy Women Study" Presented at American Heart Association Meeting and Featured on CBS Evening News With Dan Rather Imatron Inc. (Nasdaq: IMAT) announced today that a University of Pittsburgh study presented on November 10, 1998 at the 71st American Heart Association meeting in Dallas found that Imatron's electron beam tomography (EBT) technology accurately predicts the development of life threatening heart disease in women. The 15-year study, supported by grants from the National Institutes of Health, revealed that Imatron's EBT technology can predict with remarkable accuracy those women in their 40s and 50s, with no clinical signs of atherosclerosis, who will ultimately develop heart disease>> ~T.